Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease.
Jara Sánchez
C
C
Department of Oncology. Electronic address: cjara@fhalcorcon.es.
Olier Gárate
C
C
Department of Oncology.
García-Donas Jiménez
J
J
Department of Oncology.
Peñalver Párraga
J
J
Department of Hematology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016190:Carboplatin / Q000008:administration & dosage; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D000077143:Docetaxel; D005260:Female; D006801:Humans; D043823:Taxoids / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced*; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D043823:Taxoids; D000077143:Docetaxel; D016190:Carboplatin; D000068878:Trastuzumab